A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.

Name: A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma.
Author: Amengual, Jennifer E

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. — المؤلف: Amengual, Jennifer E — Blood 20190513

المؤلف: Amengual, Jennifer E
النشر: Blood 20190513
الوصف: 397-407 p.
الموضوعات: Adult؛ Aged؛ Aminopterin؛ Antibiotics, Antineoplastic؛ Antineoplastic Combined Chemotherapy Protocols؛ Depsipeptides؛ Female؛ Folic Acid Antagonists